Insights On Drug Development

1. Supporting Late-Stage Drug Product Development 6/29/2026

   Meet Coriolis Pharma at CPHI Worldwide in Milan to explore solutions for late-stage drug product development, manufacturing readiness, and CMC support.

2. Structuring ADC Analytical Partnerships From Pre-IND To Commercial 6/17/2026

   ADC success depends less on molecular design than on a continuous analytical strategy that connects early characterization to late-stage control, preventing variability, data gaps, and regulatory issues from compounding over time.

3. Choosing The Right Ligand Binding Assay Platform For Drug Development 6/17/2026

   Choosing the wrong ligand binding assay platform early in drug development can cost you time, data quality, and regulatory standing. Learn what actually drives platform selection for biologics.

4. Data-Driven Strategies To De-Risk OSD Development 6/17/2026

   Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.

5. How Adept Formulation Helps Overcome Manufacturability Challenges 6/17/2026

   Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.

6. ADCs As Biological Missiles For Targeted Therapies 6/15/2026

   Antibody-drug conjugates are reshaping cancer treatment. Learn how monoclonal antibody targeting, linker design, and next-gen payloads are defining the future of precision oncology.

7. Developing A Multi-Drug Combination, Antiparasitic Drug For Dogs 6/15/2026

   Looking to bring an innovative animal health product to market? See how we delivered end-to-end formulation development and rapid clinical supply manufacturing for complex multi-API products.

8. Solving Formulation Challenges Across Modalities 6/15/2026

   Optimize drug delivery by leveraging advanced nanoparticle engineering to dramatically increase small-molecule oral drug loading and enable ultra-high-concentration subcutaneous formulations.

9. Batch Manufacturing Vs Continuous Manufacturing With Process Analytical Technology 6/15/2026

   Batch or continuous manufacturing? The answer depends heavily on how you use process analytical technology. Understand the tradeoffs before your next program decision.

10. Coordinated Development As An Execution Framework 6/9/2026

    See how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.